. . . . . . . . . . . . . . . . . . . . . . "TextLocation" . "Results" . "a(SCHEM:\"PD 98,059\") -| (p(RGD:Igf1) -> kin(p(PFR:\"MAPK Erk1/3 Family\")))" . "p(RGD:Igf1) -> kin(p(PFR:\"MAPK Erk1/3 Family\"))" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "1.6" . "Intracellular signaling. Infusion of IGF-I resulted in an approximate fivefold increase\nin the phosphorylation of ERKs 1 and 2 (Fig. 4), whereas the total ERK levels\nwere unchanged vs. contralateral muscles (data not shown). Coinfusion (IGF+PD)\ncompletely blunted the increase in ERK1 phosphorylation and significantly reduced\nthe increase in ERK2 phosphorylation (Fig. 4B). Similar to ERK2, the phosphorylation\nof S6K1 was increased fivefold in the IGF and 2.8-fold in the IGF+PD\nmuscles (Fig. 5). The infusion protocols did not impact the total amount of S6K1\n(data not shown)." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:29:34.212+02:00"^^ . . .